Aspirin

Daily aspirin use after standard adjuvant therapy did not improve DFS for patients with colorectal cancer, according to results of a randomized phase 3 study.

In this video, Michael Cecchini, MD, discussed data from the ALASCCA trial, which followed patients with colorectal cancer who were treated with a large dose of aspirin.

In a study of approximately 386,000 women published in JAMA Network Open, almost half of those who took antidepressants before conception stopped treatment during pregnancy without substituting psychotherapy.

In a systematic review and meta-analysis of trials of non-vitamin K oral anticoagulants vs. single antiplatelet therapy, rivaroxaban was associated with higher rates of major bleeding compared with low-dose aspirin, researchers reported.

The Preeclampsia Foundation launched a new initiative that aims to close the maternal health equity gap and promote the use of low-dose aspirin to reduce preeclampsia risk in Black women.

The American Heart Association has issued its heart disease and stroke statistical update for 2025, which provides an overview of statistics related to CVD, stroke and CV risk factors.

Many historically underrepresented groups, individuals on Medicaid and some without insurance at low atherosclerotic risk continue to take low-dose aspirin despite bleeding risk, in contrast to recent clinical guidance, researchers found.

Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations in the PI3K pathway, according to results of the randomized ALASCCA study presented at ASCO Gastrointestinal Cancers Symposium.

Aspirin was not linked to the risk of nonfatal atherosclerotic CVD or cardiovascular death in adults with chronic kidney disease, according to recently published data.

Low-dose aspirin use was significantly associated with an increased risk for anemia among older Danish adults in a real-world setting, according to a study published in European Heart Journal – Quality of Care and Clinical Outcomes.